Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Product containing caffeine and dihydrocodeine tartrate and paracetamol |
Is a |
Product containing dihydrocodeine (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing caffeine and dihydrocodeine tartrate and paracetamol |
Is a |
Product containing paracetamol (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing caffeine and dihydrocodeine tartrate and paracetamol |
Is a |
Product containing caffeine (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing caffeine and dihydrocodeine tartrate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Paracetamol |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing caffeine and dihydrocodeine tartrate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dihydrocodeine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing caffeine and dihydrocodeine tartrate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Caffeine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing caffeine and dihydrocodeine tartrate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bronchodilator |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing caffeine and dihydrocodeine tartrate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Non-opioid analgesics |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing caffeine and dihydrocodeine tartrate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Stimulant (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing caffeine and dihydrocodeine tartrate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dihydrocodeine bitartrate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing caffeine and dihydrocodeine tartrate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phosphodiesterase inhibitor |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing caffeine and dihydrocodeine tartrate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Opioid receptor agonist |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing caffeine and dihydrocodeine tartrate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Xanthine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing caffeine and dihydrocodeine tartrate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
tartrate de dihydrocodéine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing caffeine and dihydrocodeine tartrate and paracetamol |
Is a |
Acetaminophen compound preparation |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|